Adjuvant denosumab for early breast cancer–Evidence and controversy

The efficacy of adjuvant denosumab in combination with hormonotherapy in breast cancer patients was investigated in two randomized trials, ABCSG-18 and D-Care, but the results were mixed with respect to the impact of this drug on disease-free survival. However, the ABCSG-18 study has achieved its pr...

Full description

Bibliographic Details
Main Authors: Laura Moretti, Laura Richelmi, Deborah Cosentini, Rebecca Pedersini, Salvatore Grisanti, Vito Amoroso, Alfredo Berruti, Marta Laganà
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Breast
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977624001577